Požymis
Dizziness
Klinikinis pavadinimas: Vertigo
An abnormal sensation of spinning while the body is actually stationary.
Santrauka
- Taip pat vadinama
- Dizzy spell
- Kūno sistema
- Abnormality of the ear
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Dizziness, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test140 genų susiję su Dizziness
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Dizziness. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ATP6V1B1ATPase H+ transporting V1 subunit B1 | Visada | 1 ligoje |
| EMDemerin | Visada | 1 ligoje |
| FDXRferredoxin reductase | Visada | 1 ligoje |
| GCGRglucagon receptor | Visada | 1 ligoje |
| LAMB1laminin subunit beta 1 | Visada | 1 ligoje |
| MAU2MAU2 sister chromatid cohesion factor | Visada | 1 ligoje |
| NOTCH3notch receptor 3 | Visada | 1 ligoje |
| RFC4replication factor C subunit 4 | Visada | 1 ligoje |
| RRP12ribosomal RNA processing 12 homolog | Visada | 2 ligose |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Visada | 2 ligose |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Visada | 1 ligoje |
| ADA2adenosine deaminase 2 | Labai dažnai (80–99%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Labai dažnai (80–99%) | 6 ligose |
| EPORerythropoietin receptor | Labai dažnai (80–99%) | 2 ligose |
| JAK2Janus kinase 2 | Labai dažnai (80–99%) | 4 ligose |
| JUPjunction plakoglobin | Labai dažnai (80–99%) | 1 ligoje |
| NAGAalpha-N-acetylgalactosaminidase | Labai dažnai (80–99%) | 3 ligose |
| SLC1A3solute carrier family 1 member 3 | Labai dažnai (80–99%) | 2 ligose |
| ABCC9ATP binding cassette subfamily C member 9 | Dažnai (30–79%) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Dažnai (30–79%) | 2 ligose |
| BCORBCL6 corepressor | Dažnai (30–79%) | 1 ligoje |
| CACNB4calcium voltage-gated channel auxiliary subunit beta 4 | Dažnai (30–79%) | 2 ligose |
| CALRcalreticulin | Dažnai (30–79%) | 1 ligoje |
| CCND1cyclin D1 | Dažnai (30–79%) | 2 ligose |
| CMPK2cytidine/uridine monophosphate kinase 2 | Dažnai (30–79%) | 1 ligoje |
| DKK1dickkopf Wnt signaling pathway inhibitor 1 | Dažnai (30–79%) | 1 ligoje |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Dažnai (30–79%) | 1 ligoje |
| GATA2GATA binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| GATA4GATA binding protein 4 | Dažnai (30–79%) | 1 ligoje |
| GATA5GATA binding protein 5 | Dažnai (30–79%) | 1 ligoje |
| GATA6GATA binding protein 6 | Dažnai (30–79%) | 1 ligoje |
| GJA5gap junction protein alpha 5 | Dažnai (30–79%) | 1 ligoje |
| GYG1glycogenin 1 | Dažnai (30–79%) | 1 ligoje |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| JAM2junctional adhesion molecule 2 | Dažnai (30–79%) | 1 ligoje |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Dažnai (30–79%) | 2 ligose |
| KCNA5potassium voltage-gated channel subfamily A member 5 | Dažnai (30–79%) | 1 ligoje |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Dažnai (30–79%) | 1 ligoje |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Dažnai (30–79%) | 1 ligoje |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 100 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Dažnai (30–79%) | 1 ligoje |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Dažnai (30–79%) | 1 ligoje |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Dažnai (30–79%) | 1 ligoje |
| LRP4LDL receptor related protein 4 | Dažnai (30–79%) | 1 ligoje |
| MPLMPL proto-oncogene, thrombopoietin receptor | Dažnai (30–79%) | 2 ligose |
| MYD88MYD88 innate immune signal transduction adaptor | Dažnai (30–79%) | 1 ligoje |
| MYL4myosin light chain 4 | Dažnai (30–79%) | 1 ligoje |
| MYORGmyogenesis regulating glycosidase | Dažnai (30–79%) | 1 ligoje |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| NABP1nucleic acid binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| NKX2-5NK2 homeobox 5 | Dažnai (30–79%) | 2 ligose |
| NKX2-6NK2 homeobox 6 | Dažnai (30–79%) | 1 ligoje |
| NPM1nucleophosmin 1 | Dažnai (30–79%) | 1 ligoje |
| NPPAnatriuretic peptide A | Dažnai (30–79%) | 2 ligose |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Dažnai (30–79%) | 1 ligoje |
| NUMA1nuclear mitotic apparatus protein 1 | Dažnai (30–79%) | 1 ligoje |
| NUP155nucleoporin 155 | Dažnai (30–79%) | 1 ligoje |
| PDGFBplatelet derived growth factor subunit B | Dažnai (30–79%) | 2 ligose |
| PDGFRBplatelet derived growth factor receptor beta | Dažnai (30–79%) | 1 ligoje |
| PITX2paired like homeodomain 2 | Dažnai (30–79%) | 1 ligoje |
| PMLPML nuclear body scaffold | Dažnai (30–79%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Dažnai (30–79%) | 1 ligoje |
| PRRT2proline rich transmembrane protein 2 | Dažnai (30–79%) | 1 ligoje |
| RARAretinoic acid receptor alpha | Dažnai (30–79%) | 1 ligoje |
| RYR1ryanodine receptor 1 | Dažnai (30–79%) | 1 ligoje |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Dažnai (30–79%) | 2 ligose |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Dažnai (30–79%) | 2 ligose |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Dažnai (30–79%) | 1 ligoje |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Dažnai (30–79%) | 1 ligoje |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Dažnai (30–79%) | 1 ligoje |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Dažnai (30–79%) | 3 ligose |
| SH2B3SH2B adaptor protein 3 | Dažnai (30–79%) | 2 ligose |
| SLC20A2solute carrier family 20 member 2 | Dažnai (30–79%) | 1 ligoje |
| SRPK3SRSF protein kinase 3 | Dažnai (30–79%) | 1 ligoje |
| STAT3signal transducer and activator of transcription 3 | Dažnai (30–79%) | 1 ligoje |
| STAT5Bsignal transducer and activator of transcription 5B | Dažnai (30–79%) | 1 ligoje |
| SUFUSUFU negative regulator of hedgehog signaling | Dažnai (30–79%) | 1 ligoje |
| TBL1XR1TBL1X/Y related 1 | Dažnai (30–79%) | 1 ligoje |
| TET2tet methylcytosine dioxygenase 2 | Dažnai (30–79%) | 1 ligoje |
| TP53tumor protein p53 | Dažnai (30–79%) | 1 ligoje |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Dažnai (30–79%) | 1 ligoje |
| TTNtitin | Dažnai (30–79%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Dažnai (30–79%) | 2 ligose |
| VSX1visual system homeobox 1 | Dažnai (30–79%) | 1 ligoje |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Dažnai (30–79%) | 1 ligoje |
| ZBTB16zinc finger and BTB domain containing 16 | Dažnai (30–79%) | 1 ligoje |
| AIPAHR interacting HSP90 co-chaperone | Kartais (5–29%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Kartais (5–29%) | 1 ligoje |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Kartais (5–29%) | 1 ligoje |
| CCR1C-C motif chemokine receptor 1 | Kartais (5–29%) | 1 ligoje |
| CDH23cadherin related 23 | Kartais (5–29%) | 2 ligose |
| CHD2chromodomain helicase DNA binding protein 2 | Kartais (5–29%) | 1 ligoje |
| CNNM2cyclin and CBS domain divalent metal cation transport mediator 2 | Kartais (5–29%) | 1 ligoje |
| CUX2cut like homeobox 2 | Kartais (5–29%) | 1 ligoje |
| DBHdopamine beta-hydroxylase | Kartais (5–29%) | 1 ligoje |
| DNM1dynamin 1 | Kartais (5–29%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Kartais (5–29%) | 1 ligoje |
| FASFas cell surface death receptor | Kartais (5–29%) | 2 ligose |
| FGF14fibroblast growth factor 14 | Kartais (5–29%) | 1 ligoje |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Kartais (5–29%) | 1 ligoje |
| FOXI1forkhead box I1 | Kartais (5–29%) | 1 ligoje |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Kartais (5–29%) | 1 ligoje |
| GCDHglutaryl-CoA dehydrogenase | Kartais (5–29%) | 1 ligoje |
| GLAgalactosidase alpha | Kartais (5–29%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Kartais (5–29%) | 3 ligose |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Kartais (5–29%) | 2 ligose |
| IFNGR1interferon gamma receptor 1 | Kartais (5–29%) | 1 ligoje |
| IL10interleukin 10 | Kartais (5–29%) | 1 ligoje |
| IL12Ainterleukin 12A | Kartais (5–29%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Kartais (5–29%) | 1 ligoje |
| IL12Binterleukin 12B | Kartais (5–29%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Kartais (5–29%) | 1 ligoje |
| KCNJ10potassium inwardly rectifying channel subfamily J member 10 | Kartais (5–29%) | 1 ligoje |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Kartais (5–29%) | 1 ligoje |
| KLRC4killer cell lectin like receptor C4 | Kartais (5–29%) | 1 ligoje |
| MAPK10mitogen-activated protein kinase 10 | Kartais (5–29%) | 1 ligoje |
| MED12mediator complex subunit 12 | Kartais (5–29%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Kartais (5–29%) | 1 ligoje |
| MEN1menin 1 | Kartais (5–29%) | 1 ligoje |
| MLXMAX dimerization protein MLX | Kartais (5–29%) | 1 ligoje |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Kartais (5–29%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Kartais (5–29%) | 2 ligose |
| SLC26A4solute carrier family 26 member 4 | Kartais (5–29%) | 1 ligoje |
| STAT4signal transducer and activator of transcription 4 | Kartais (5–29%) | 1 ligoje |
| THPOthrombopoietin | Kartais (5–29%) | 1 ligoje |
| TLR4toll like receptor 4 | Kartais (5–29%) | 1 ligoje |
| TNFRSF1ATNF receptor superfamily member 1A | Kartais (5–29%) | 1 ligoje |
| UBAC2UBA domain containing 2 | Kartais (5–29%) | 1 ligoje |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Retai (1–4 %) | 1 ligoje |
| CLCNKBchloride voltage-gated channel Kb | Retai (1–4 %) | 1 ligoje |
| CTNNB1catenin beta 1 | Retai (1–4 %) | 1 ligoje |
| NOP56NOP56 ribonucleoprotein | Retai (1–4 %) | 1 ligoje |
| SLC12A3solute carrier family 12 member 3 | Retai (1–4 %) | 2 ligose |
| CALM1calmodulin 1 | Neužfiksuota | 1 ligoje |
| COCHcochlin | Neužfiksuota | 1 ligoje |
| MVKmevalonate kinase | Neužfiksuota | 1 ligoje |
| MYL2myosin light chain 2 | Neužfiksuota | 1 ligoje |
| MYO7Amyosin VIIA | Neužfiksuota | 2 ligose |
| TPK1thiamin pyrophosphokinase 1 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites